The Zika virus is a mosquito-borne virus that can cause mild symptoms but poses serious risks, especially for pregnant women, as it can lead to birth defects. Early and accurate detection is vital for preventing complications and controlling the spread of the virus.
At Goffin Molecular Technologies BV, we offer a high-performance Point-of-Care test for Zika, compatible with our IGenesis platform. This rapid test allows healthcare professionals to quickly identify the virus, enabling timely intervention and reducing health risks. Fast testing is essential for managing outbreaks and protecting at-risk populations, making our IGenesis platform an ideal solution for efficient Zika detection.
Subscribe to our newsletter.